H. Sprecher - Concepedia

Author

H. Sprecher

Rambam Health Care Campus

Also Known As

H Sprecher, H. Sprecher, Hanna Sprecher, Sprecher Hanna

Publications

729

Citations

H-Index

Concepts

All Affiliations

Rambam Health Care Campus Technion – Israel Institute of Technology

About

H. Sprecher is an author at Rambam Health Care Campus specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	266
2	Microbiology	4	4	155
3	Health Sciences	3	3	124
4	Pathology	2	2	53
5	Pharmacology	1	1	69

H. Sprecher

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Carbapenem Resistance Among <i>Klebsiella pneumoniae</i> Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns Khetam Hussein, H. Sprecher, Tania Mashiach, Infection Control and Hospital Epidemiology	2009	208
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state Tsila Zuckerman, Noam Benyamini, H. Sprecher, Bone Marrow Transplantation Oral GentamicinAntimicrobial SusceptibilityHealth SciencesAntibioticsCarrier State	2010	78
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients I. Oren, J M Rowe, H. Sprecher, Bone Marrow Transplantation Antifungal AgentMedicineFungal InfectionsClinical MycologyPharmacology	2006	69
Comparison of Invasive and Non-Invasive Tests Diagnosis and Monitoring of Helicobacter Pylori Infection in Children B. Hino, Rami Eliakim, Arie Levine, Journal of Pediatric Gastroenterology and Nutrition	2004	60
Acremonium Vertebral Osteomyelitis: Molecular Diagnosis and Response to Voriconazole Yoav Keynan, H. Sprecher Clinical Infectious Diseases Diagnostic MycologyAntifungal AgentOsteopathyParasitic ProtozoaAntifungal Agents	2007	30
Epidemiology and clinical significance of non-tuberculous mycobacteria isolated from pulmonary specimens Eyal Braun, H. Sprecher, Sima Davidson, The International Journal of Tuberculosis and Lung Disease	2012	28
First national surveillance of susceptibility of extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel Raul Colodner, Zmira Samra, Nathan Keller, Diagnostic Microbiology and Infectious Disease Antimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial Stewardship	2007	27
Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome Emília Hardak, Mordechai Yigla, Irit Avivi, Bone Marrow Transplantation Molecular Diagnostic TechniquesAdvanced Lung DiseaseDiagnosisPathologyInvasive Pulmonary Aspergillosis	2009	23
Disseminated dermatophytic pseudomycetoma caused by <i>Microsporum</i> species Tirado-Gonzalez Mariantonieta, Elízabeth Ball, Ángela María Ruiz-Sternberg, International Journal of Dermatology	2012	22
Radiological findings of early invasive pulmonary aspergillosis in immune‐compromised patients Luda Guralnik, Emília Hardak, I. Oren, Hematological Oncology	2009	21

Page 1